Literature DB >> 30666491

Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase.

Annah N Mpitimpiti1, Jacobus P Petzer2,3, Anél Petzer1,4, Johannes H L Jordaan5, Anna C U Lourens1,4.   

Abstract

Based on reports that chromone compounds are good potency inhibitors of monoamine oxidase (MAO), the present study evaluates the effect of substitution with flexible side chains on the 3 position on MAO inhibition potency. Fifteen chromone derivatives were synthesised by reacting aromatic and aliphatic amines and alcohols with chromone 3-carboxylic acid in the presence of carbonyldiimidazole (CDI). This yielded chromane-2,4-dione and ester chromone derivatives. Generally, the esters exhibited weak MAO inhibition, while the chromane-2,4-dione derivatives showed promise as selective MAO-B inhibitors with IC50 values in the micromolar range. Compound 14b, 3-[(benzylamino)methylidene]-3,4-dihydro-2H-1-benzopyran-2,4-dione, was the most potent MAO-B inhibitor with an IC50 value of 638 µM. This compound was shown to be a reversible and competitive MAO-B inhibitor with a Ki of 94 µM. In conclusion, the effect of chain elongation and introduction of flexible substituents on position 3 of chromone were explored and the results showed that aminomethylidene substitution is preferable over ester substitution. Good potency MAO-B inhibitors may act as leads for the design and development of therapy for Parkinson's disease where these agents reduce the central metabolism of dopamine.

Entities:  

Keywords:  Chromandione; Chromone; Competitive; Inhibitor; MAO; Monoamine oxidase; Parkinson’s disease

Mesh:

Substances:

Year:  2019        PMID: 30666491     DOI: 10.1007/s11030-019-09917-8

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  43 in total

1.  Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders.

Authors:  Claudia Binda; Paige Newton-Vinson; Frantisek Hubálek; Dale E Edmondson; Andrea Mattevi
Journal:  Nat Struct Biol       Date:  2002-01

Review 2.  Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).

Authors:  Simone Carradori; Jacobus P Petzer
Journal:  Expert Opin Ther Pat       Date:  2014-11-15       Impact factor: 6.674

3.  Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.

Authors:  Stefano Alcaro; Alexandra Gaspar; Francesco Ortuso; Nuno Milhazes; Francisco Orallo; Eugenio Uriarte; Matilde Yáñez; Fernanda Borges
Journal:  Bioorg Med Chem Lett       Date:  2010-03-27       Impact factor: 2.823

4.  Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.

Authors:  Alexandra Gaspar; Joana Reis; André Fonseca; Nuno Milhazes; Dolores Viña; Eugenio Uriarte; Fernanda Borges
Journal:  Bioorg Med Chem Lett       Date:  2010-12-05       Impact factor: 2.823

5.  Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase.

Authors:  Anél Petzer; Brian H Harvey; Gregers Wegener; Jacobus P Petzer
Journal:  Toxicol Appl Pharmacol       Date:  2011-12-16       Impact factor: 4.219

6.  Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.

Authors:  Alexandra Gaspar; Tiago Silva; Matilde Yáñez; Dolores Vina; Franscisco Orallo; Francesco Ortuso; Eugenio Uriarte; Stefano Alcaro; Fernanda Borges
Journal:  J Med Chem       Date:  2011-07-01       Impact factor: 7.446

7.  Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors.

Authors:  María Carmen Costas-Lago; Pedro Besada; Fernanda Rodríguez-Enríquez; Dolores Viña; Santiago Vilar; Eugenio Uriarte; Fernanda Borges; Carmen Terán
Journal:  Eur J Med Chem       Date:  2017-07-25       Impact factor: 6.514

8.  Age-related increases in brain monoamine oxidase B in living healthy human subjects.

Authors:  J S Fowler; N D Volkow; G J Wang; J Logan; N Pappas; C Shea; R MacGregor
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

9.  Selected chromone derivatives as inhibitors of monoamine oxidase.

Authors:  Lesetja J Legoabe; Anél Petzer; Jacobus P Petzer
Journal:  Bioorg Med Chem Lett       Date:  2012-07-14       Impact factor: 2.823

10.  Synthesis, characterization, monoamine oxidase inhibition, molecular docking and dynamic simulations of novel 2,1-benzothiazine-2,2-dioxide derivatives.

Authors:  Shakeel Ahmad; Sumera Zaib; Saquib Jalil; Muhammad Shafiq; Matloob Ahmad; Sadia Sultan; Mazhar Iqbal; Sana Aslam; Jamshed Iqbal
Journal:  Bioorg Chem       Date:  2018-04-19       Impact factor: 5.275

View more
  2 in total

Review 1.  Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.

Authors:  Hari Madhav; Ehtesham Jameel; Mohammad Rehan; Nasimul Hoda
Journal:  RSC Med Chem       Date:  2022-01-31

2.  Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling.

Authors:  Begüm Nurpelin Sağlık; Betül Kaya Çavuşoğlu; Ulviye Acar Çevik; Derya Osmaniye; Serkan Levent; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  RSC Med Chem       Date:  2020-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.